Table 2.
3 Weeks | DBBM |
n = 4 mean % = 3,47 (95% CI: -0,74 – 7,69) |
L-PRF |
n = 3 mean % = 10,09 (95% CI: 9,45 – 29,64) |
|
DBBM + L-PRF |
n = 4 mean % = 3,16 (95% CI: 0,78 – 5,53)* |
|
Control |
n = 4 mean % = 11,58 (95% CI: 3,66 – 19,50)* |
|
Kruskal Wallis (p = 0,049); Mann-Withney U (p < 0,05)* | ||
6 Weeks | DBBM |
n = 4 mean % = 4,24 (95% CI: 0,10 – 8,37) |
L-PRF |
n = 4 mean % = 6,43 (95% CI: -5,54 – 18,39) |
|
DBBM + L-PRF |
n = 3 mean % = 4,36 (95% CI: -2,43 – 11,15) |
|
Control |
n = 4 mean % = 8,31 (95% CI: 0,95 – 15,66) |
|
Kruskal Wallis (p = 0,587) | ||
9 Weeks | DBBM |
n = 3 mean % = 4,04 (95% CI: -1,06 – 9,13) |
L-PRF |
n = 3 mean % = 17,65 (95% CI: -14,48 – 49,77) |
|
DBBM + L-PRF |
n = 3 mean % = 12,28 (95% CI: -1,78 – 84,33) |
|
Control |
n = 4 mean % = 24,08 (95% CI: 4,50 – 43,67) |
|
Kruskal Wallis (p = 0,135) |
DBBM: bovine derived deproteinized xenograft. L-PRF: leukocyte and platelet rich fibrin. CI: Confidence interval. Symbol *: significative difference between those groups.